ZA812600B - A pharmaceutical composition for oral administration containing cytidin diphosphocholine - Google Patents

A pharmaceutical composition for oral administration containing cytidin diphosphocholine

Info

Publication number
ZA812600B
ZA812600B ZA00812600A ZA812600A ZA812600B ZA 812600 B ZA812600 B ZA 812600B ZA 00812600 A ZA00812600 A ZA 00812600A ZA 812600 A ZA812600 A ZA 812600A ZA 812600 B ZA812600 B ZA 812600B
Authority
ZA
South Africa
Prior art keywords
cytidin
diphosphocholine
pharmaceutical composition
oral administration
administration containing
Prior art date
Application number
ZA00812600A
Other languages
English (en)
Inventor
E Borgo
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of ZA812600B publication Critical patent/ZA812600B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00812600A 1980-04-18 1981-04-21 A pharmaceutical composition for oral administration containing cytidin diphosphocholine ZA812600B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (1)

Publication Number Publication Date
ZA812600B true ZA812600B (en) 1982-04-28

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00812600A ZA812600B (en) 1980-04-18 1981-04-21 A pharmaceutical composition for oral administration containing cytidin diphosphocholine

Country Status (15)

Country Link
US (1) US4386077A (es)
AT (1) AT376366B (es)
AU (1) AU544469B2 (es)
BE (1) BE890796A (es)
CH (1) CH652026A5 (es)
DE (1) DE3115080C2 (es)
DK (1) DK173081A (es)
ES (1) ES502080A0 (es)
FR (1) FR2480603B1 (es)
GB (1) GB2074445B (es)
IN (1) IN156105B (es)
IT (1) IT1207106B (es)
NL (1) NL8101899A (es)
SE (1) SE447449B (es)
ZA (1) ZA812600B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
PL185124B1 (pl) * 1995-03-06 2003-02-28 Interneuron Pharmaceuticals Zastosowanie cytykoliny oraz jej kompozycja do wytwarzania leku przeznaczonego do ochrony tkanki mózgowej
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
AU2001247474A1 (en) * 2000-03-16 2001-09-24 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
US20060189566A1 (en) * 2003-02-26 2006-08-24 Miho Komatsu Muscle building agent and preventive or remedy for muscle weakening
US7737128B2 (en) * 2004-06-10 2010-06-15 The Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (es) * 1969-08-04 1973-12-07
JPS4886869A (es) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
BE890796A (fr) 1982-02-15
US4386077A (en) 1983-05-31
DE3115080C2 (de) 1986-10-16
DE3115080A1 (de) 1982-02-25
CH652026A5 (it) 1985-10-31
SE8102456L (sv) 1981-10-19
AU6994581A (en) 1981-10-22
IN156105B (es) 1985-05-18
FR2480603A1 (fr) 1981-10-23
ES8207184A1 (es) 1982-09-01
AU544469B2 (en) 1985-05-30
AT376366B (de) 1984-11-12
GB2074445B (en) 1983-09-07
ATA172081A (de) 1984-04-15
SE447449B (sv) 1986-11-17
GB2074445A (en) 1981-11-04
FR2480603B1 (fr) 1985-07-12
ES502080A0 (es) 1982-09-01
NL8101899A (nl) 1981-11-16
DK173081A (da) 1981-10-19
IT8048454A0 (it) 1980-04-18
IT1207106B (it) 1989-05-17

Similar Documents

Publication Publication Date Title
IL63036A (en) Dosage units for oral administration
ZA837307B (en) Oral dosage form
GB8319407D0 (en) Medicinal composition containing pirprofen
AU572800B2 (en) Pharmaceutical compositions containing a calcitonin
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
DE3571549D1 (en) Pharmaceutical composition containing a hydroxypyrone-iron complex
EP0180364A3 (en) Pharmaceutical compositions containing phenothiazines
GB2085729B (en) Pharmaceutical composition for oral administration containing coagulation factor viii
ZA812600B (en) A pharmaceutical composition for oral administration containing cytidin diphosphocholine
GB2142821B (en) Pharmaceutical compositions containing plant gums
IL67336A0 (en) Pharmaceutical composition containing vitamin a
ZA83130B (en) A pharmaceutical composition
SG7085G (en) Pharmaceutical compositions for a mouthwash
EG15051A (en) Pharmaceutical formulations containing a preservatives
IL87943A (en) Pharmaceutical compositions containing a piperidinoalkanol-decongestant combination
GB2077100B (en) Pharmaceutical compositions containing cromoglycates
PH18051A (en) 3,4-bis-substituted 1,2,5-oxdiazole 2-oxides,a process for their preparation,and pharmaceutical formulations containing them
IL84387A0 (en) Pharmaceutical compositions containing a substituted phosphatide
DE3267248D1 (en) Retard oral pharmaceutical compositions
ATA409082A (de) Buegel zum aufhaengen von rasterdeckenelementen
GB2052980B (en) Pharmaceutical composition for oral administration comprising methoxsalen
JPS57206615A (en) Medicinal composition containing guanfasin
IL65976A0 (en) Pharmaceutical compositions comprising a d-homosteroid
PH17043A (en) A pharmaceutical composition for oral administration containing cytidin diphosphocholine
DE3163391D1 (en) A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient